MPR Weekly Dose 137 — USPSTF Hormone Recommendations; Semaglutide in Obese Teens; Maternal RSV Vaccine Candidate; Antipsychotic REMS Update; Omburtamab Panel Vote
USPSTF recommendations on estrogen and progesterone; semaglutide assessed in obese teenagers; efficacy and safety data released for maternal RSV vaccine; updates to clozapine REMS; FDA panel vote on i...
4 Marras 202215min
MPR Weekly Dose 136 — Approvals in Multiple Myeloma, Axial Spondyloarthritis, and Hepatocellular Carcinoma; FDA Panel Vote; Oral Suspension of Tadalafil
Approvals for relapsed or refractory multiple myeloma, non-radiographic axial spondyloarthritis, and unresectable hepatocellular carcinoma; advisory committee takes vote on potential treatment for ane...
28 Loka 202213min
MPR Weekly Dose 135 — Makena Panel Vote; Apixaban vs Rivaroxaban; Monkeypox Ocular Complications; Novavax COVID-19 Booster; Sparsentan, Tofersen Reviews Extended
FDA Panel votes on the potential removal from the market of Makena; results from an apixaban trial of patients with atrial fibrillation and valvular heart disease; reports of serious ocular complicati...
21 Loka 202216min
MPR Weekly Dose 134 — Vaccine Boosters Authorized; Wearable Furosemide System Approved; Molnupiravir Data; Pertussis Vaccine; FDA Apomorphine Device Update
Bivalent COVID-19 booster vaccines for children; wearable device to help treat fluid overload in adults with chronic heart failure; real-world data insights into molnupiravir efficacy; vaccine for the...
14 Loka 202216min
MPR Weekly Dose 133 — ALS Treatment Approval; Evusheld Update; At-Home Epilepsy Diagnosis; Clopidogrel, Atenolol Recall; Laser Therapy for Fibromyalgia
ALS treatment news; Evusheld fact sheet update; an at-home epilepsy diagnostic aid gets cleared; drug recalls; and a laser therapy for fibromyalgia.
7 Loka 202211min
MPR Weekly Dose 132 — Social Media Warning; Cisplatin-Associated Ototoxicity Tx; New Cerebral Adrenoleukodystrophy Tx; MRI Contrast Agent; Generic Tazorac
This week we go over warnings about a new social media challenge; treatment approvals in cisplatin-associated ototoxicity, cerebral adrenoleukodystrophy, MRI contrast agents and a generic version of t...
23 Syys 202213min
MPR Weekly Dose 131 — Approvals in Plaque Psoriasis, Hepatorenal Syndrome and Neutropenia; Priority Review for Rett Syndrome Therapy; Multivitamins Assessed in Cognition
Approvals in psoriasis, hepatorenal syndrome, and neutropenia; novel therapy gains Priority Review for Rett Syndrome; and the effects of multivitamin supplementation assessed on cognitive function.
16 Syys 202213min
MPR Weekly Dose 130 — FDA Vote on ALS Treatment; CPAP, BiPAP Recall; CRISPR Therapy for Hereditary Angioedema; Imfinzi Approved for Biliary Tract Cancer; Spevigo Approved
Hello listener and welcome to episode 130 of the MPR Weekly Dose Podcast. This week we have news of the FDA's vote on an ALS treatment; CPAP and BiPAP device recalls; Orphan Drug designation for a nov...
9 Syys 202213min
